Related Experiment Videos
Relationship between serum copper and bone marrow blasts in acute leukaemia
Haematologia
|January 1, 1977
Summary
Serum copper levels correlate significantly with acute lymphoblastic leukemia (ALL) progression in children. Elevated copper indicates increased leukemia cells and may aid in managing childhood leukemia.
Area of Science:
- Pediatric Hematology
- Oncology
- Biochemistry
Background:
- Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
- Biomarkers are needed for effective ALL management and monitoring.
- Serum copper levels (SCL) have been investigated in various conditions.
Purpose of the Study:
- To investigate the correlation between serum copper levels (SCL) and disease status in children with acute lymphoblastic leukemia (ALL).
- To determine if SCL can serve as a prognostic indicator in pediatric ALL.
Main Methods:
- Collected serum and bone marrow samples from 45 children diagnosed with ALL.
- Analyzed SCL in conjunction with bone marrow blast percentage and disease progression markers.
- Correlated SCL with clinical parameters such as hyperleukocytosis and leukaemic tumors.
Main Results:
- A highly significant positive correlation was found between SCL and bone marrow blasts in pediatric ALL patients.
- Increasing SCL levels were associated with ALL progression and higher percentages of marrow parablasts.
- The highest mean SCL was observed in patients with extensive marrow involvement, hyperleukocytosis, and leukaemic tumors.
Conclusions:
- Serum copper levels show a strong association with disease burden and progression in childhood ALL.
- SCL may be a valuable, non-invasive biomarker for monitoring ALL activity and guiding treatment decisions in children.
- Further research can explore SCL's role in predicting treatment response and relapse in pediatric acute leukemia.